好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Diminshed Muscle Oxygenation During Exercise in Ambulatory Spinal Muscular Atrophy Patients
Neuromuscular and Clinical Neurophysiology (EMG)
P4 - Poster Session 4 (5:30 PM-6:30 PM)
12-024

To assess muscle oxygenation during exercise and associations with aerobic capacity and body composition in spinal muscular atrophy (SMA) patients.

SMA is a genetically determined neuromuscular disorder characterized by weakness and muscle atrophy. Although ubiquitous, SMN protein deficiency selectively affects lower motor neurons. Laboratory evidence suggests that muscle mitochondria may be vulnerable to SMN deficiency. Fatigue and exercise intolerance may be the clinical consequences of these laboratory observations. Understanding aerobic metabolism relative to lean body mass (LBM) may enhance understanding of mitochondrial function in SMA.

Nine ambulatory SMA participants, 6 healthy and 3 disease controls with mitochondrial myopathy were evaluated. Change in deoxygenated hemoglobin from rest to peak exertion, using near-infrared spectroscopy measured on the vastus lateralis, was used to determine muscle oxygenation (ΔMOx). Peak aerobic capacity (VO2peak) and workload (Wpeak) were measured using a cardiopulmonary exercise test performed on a recumbent ergometer. LBM was estimated with Dual Energy X-ray Absorptiometry.

 

Control groups were combined for analyses due to the small disease control sample. Independent samples t-tests were used to determine group differences. Bivariate relationships among ΔMOx, VO2peak, Wpeak and LBM were examined using Pearson correlation coefficients.

Mean ΔMOx was lower in SMA (-1.1 ± 3.6) than in controls (9.1 ± 6.7) (p = 0.002). VO2peak was associated with LBM in controls (r = 0.82; p = 0.007) and in SMA (r = 0.65; p = 0.06).  ΔMOx was associated with VO2peak (r = 0.92; p < 0.001), LBM (r = 0.84; p = 0.005), and Wpeak (r = 0.88; p = 0.002) in controls but not in SMA.

Individuals with SMA demonstrate diminished muscle oxygenation during exercise. SMA patients appear to rely on anaerobic pathways resulting in fatigue and exercise intolerance. Targeted treatments may be needed to address apparent mitochondrial disturbance in SMA.

Authors/Disclosures
Jacqueline Montes, PT, EdD, NCS (Columbia University Medical Center)
PRESENTER
Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
No disclosure on file
Michael McDermott No disclosure on file
No disclosure on file
Kayla B. Coutts, PT No disclosure on file
Ashwini K. Rao (Rehabilitation Medicine) No disclosure on file
No disclosure on file
Darryl C. De Vivo, MD, FAAN (Columbia University) Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.